Viewing Study NCT02588456

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-01-25 @ 5:59 AM
Study NCT ID: NCT02588456
Status: TERMINATED
Last Update Posted: 2023-06-22
First Post: 2015-10-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia
Sponsor: University of Pennsylvania
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia View
Keywords: